| Impact of silica nanoparticle design on cellular toxicity and hemolytic activity T Yu, A Malugin, H Ghandehari ACS nano 5 (7), 5717-5728, 2011 | 716 | 2011 |
| Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold T Yu, K Greish, LD McGill, A Ray, H Ghandehari ACS nano 6 (3), 2289-2301, 2012 | 226 | 2012 |
| In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics T Yu, D Hubbard, A Ray, H Ghandehari Journal of controlled release 163 (1), 46-54, 2012 | 210 | 2012 |
| Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles K Greish, G Thiagarajan, H Herd, R Price, H Bauer, D Hubbard, A Burckle, ... Nanotoxicology 6 (7), 713-723, 2012 | 191 | 2012 |
| Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity K Schoen, T Yu, C Stockmann, MG Spigarelli, CMT Sherwin Pediatric Drugs 16, 169-177, 2014 | 82 | 2014 |
| Herbal medicines: challenges in the modern world. Part 3. China and Japan L Teng, Q Zu, G Li, T Yu, KM Job, X Yang, L Di, CMT Sherwin, ... Expert review of clinical pharmacology 9 (9), 1225-1233, 2016 | 62 | 2016 |
| Pregnancy‐induced changes in the pharmacokinetics of caffeine and its metabolites T Yu, SC Campbell, C Stockmann, C Tak, K Schoen, EAS Clark, ... The Journal of Clinical Pharmacology 56 (5), 590-596, 2016 | 60 | 2016 |
| Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma JE Rower, X Liu, T Yu, M Mundorff, CMT Sherwin, MD Johnson European journal of clinical pharmacology 73, 325-331, 2017 | 37 | 2017 |
| Determination of optimal amikacin dosing regimens for pediatric patients with burn wound sepsis T Yu, C Stockmann, DP Healy, J Olson, S Wead, AN Neely, RJ Kagan, ... Journal of Burn Care & Research 36 (4), e244-e252, 2015 | 33 | 2015 |
| Optimal design in pediatric pharmacokinetic and pharmacodynamic clinical studies JK Roberts, C Stockmann, A Balch, T Yu, RM Ward, MG Spigarelli, ... Pediatric Anesthesia 25 (3), 222-230, 2015 | 33 | 2015 |
| AUC‐guided vancomycin dosing in adolescent patients with suspected sepsis S Lanke, T Yu, JE Rower, AH Balch, EK Korgenski, CM Sherwin The Journal of Clinical Pharmacology 57 (1), 77-84, 2017 | 32 | 2017 |
| Optimizing the use of intravenous magnesium sulfate for acute asthma treatment in children X Liu, T Yu, JE Rower, SC Campbell, CMT Sherwin, MD Johnson Pediatric pulmonology 51 (12), 1414-1421, 2016 | 32 | 2016 |
| Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections KM Job, J Olson, C Stockmann, JE Constance, EY Enioutina, JE Rower, ... Expert review of anti-infective therapy 14 (8), 731-746, 2016 | 29 | 2016 |
| Evaluation of vancomycin use in late-onset neonatal sepsis using the area under the concentration–time curve to the minimum inhibitory concentration≥ 400 target JB JJ, C Stockmann, JK Roberts, T Yu, KE Korgenski, MG Spigarelli, ... Therapeutic drug monitoring 37 (6), 756-765, 2015 | 25 | 2015 |
| Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates T Yu, AH Balch, RM Ward, EK Korgenski, CMT Sherwin BMC Pharmacology and Toxicology 17, 1-8, 2016 | 16 | 2016 |
| Clinical pharmacokinetics and pharmacodynamics of biologic therapeutics for treatment of systemic lupus erythematosus T Yu, EY Enioutina, HI Brunner, AA Vinks, CM Sherwin Clinical pharmacokinetics 56, 107-125, 2017 | 15 | 2017 |
| Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections C Stockmann, JK Roberts, T Yu, JE Constance, CAJ Knibbe, ... Expert Review of Anti-infective Therapy 12 (11), 1371-1388, 2014 | 15 | 2014 |
| Renal function descriptors in neonates: which creatinine‐based formula best describes vancomycin clearance? J Bhongsatiern, C Stockmann, T Yu, JE Constance, G Moorthy, ... The Journal of Clinical Pharmacology 56 (5), 528-540, 2016 | 11 | 2016 |
| Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999–2012 T Yu, C Stockmann, AH Balch, MG Spigarelli, CMT Sherwin International journal of antimicrobial agents 43 (3), 215-222, 2014 | 9 | 2014 |
| Pharmacokinetic considerations in the use of antivirals in neonates EY Enioutina, JE Constance, C Stockmann, MW Linakis, T Yu, JE Rower, ... Expert Opinion on Drug Metabolism & Toxicology 11 (12), 1861-1878, 2015 | 4 | 2015 |
